Related Experiment Video
Updated: Apr 26, 2026

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
Published on: December 8, 2014
Role of microbiota and innate immunity in recurrent Clostridium difficile infection
Stefano Bibbò1, Loris Riccardo Lopetuso1, Gianluca Ianiro1
1A. Gemelli Hospital, Division of Internal Medicine and Gastroenterology, Department of Internal Medicine, School of Medicine and Surgery, Catholic University, 8, 00168 Rome, Italy.
Abstract:
Recurrent Clostridium difficile infection represents a burdensome clinical issue whose epidemiology is increasing worldwide. The pathogenesis is not yet completely known. Recent observations suggest that the alteration of the intestinal microbiota and impaired innate immunity may play a leading role in the development of recurrent infection. Various factors can cause dysbiosis. The causes most involved in the process are antibiotics, NSAIDs, acid suppressing therapies, and age. Gut microbiota impairment can favor Clostridium difficile infection through several mechanisms, such as the alteration of fermentative metabolism (especially SCFAs), the alteration of bile acid metabolism, and the imbalance of antimicrobial substances production. These factors alter the intestinal homeostasis promoting the development of an ecological niche for Clostridium difficile and of the modulation of immune response. Moreover, the intestinal dysbiosis can promote a proinflammatory environment, whereas Clostridium difficile itself modulates the innate immunity through both toxin-dependent and toxin-independent mechanisms. In this narrative review, we discuss how the intestinal microbiota modifications and the modulation of innate immune response can lead to and exacerbate Clostridium difficile infection.
Insights
Recurrent Clostridium difficile infection is rising globally. Gut microbiota disruption and weakened innate immunity are key factors driving these infections, impacting patient health.
Area of Science:
- Microbiology
- Immunology
- Gastroenterology
Background:
- Recurrent Clostridium difficile infection (CDI) is a growing global health concern.
- The precise mechanisms underlying recurrent CDI remain incompletely understood.
- Alterations in gut microbiota and innate immune function are implicated in recurrent CDI pathogenesis.
Purpose of the Study:
- To review the role of intestinal microbiota modifications in recurrent CDI.
- To explore the impact of innate immunity modulation on recurrent CDI.
- To synthesize current understanding of these factors in CDI development.
Main Methods:
- Narrative review of existing literature.
- Analysis of factors contributing to gut dysbiosis (e.g., antibiotics, NSAIDs, acid suppressors, age).
- Examination of microbiota-mediated mechanisms (metabolism, bile acids, antimicrobial substances) and immune modulation.
Main Results:
- Gut dysbiosis, caused by various factors, disrupts intestinal homeostasis.
- Microbiota alterations affect SCFA and bile acid metabolism, favoring CDI.
- Clostridium difficile modulates innate immunity via toxin-dependent and independent pathways.
Conclusions:
- Intestinal dysbiosis creates an environment conducive to CDI.
- Impaired innate immunity and microbiota alterations are central to recurrent CDI.
- Understanding these interactions is crucial for managing recurrent CDI.
Related Concept Videos
Introduction to the Human Microbiota
Development of Human Microbiota
Microbiota of the Stomach and Small Intestine
Microbiota of the Large Intestine
Functions of the Gut Microbiota
Inflammatory Bowel Disease III: Crohn's Disease

